{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:07:05Z","timestamp":1789927625724,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T00:00:00Z","timestamp":1477353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/tpj.2016.65","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T10:04:15Z","timestamp":1477389855000},"page":"64-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"18","author":[{"name":"on behalf of the Paediatric Disease Working Parties of the European Blood and Marrow Transplant group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Huezo-Diaz Curtis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C R S","family":"Uppugunduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Muthukumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Rezgui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Krajinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,25]]},"reference":[{"key":"BFtpj201665_CR1","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","volume":"85","author":"SI Bearman","year":"1995","unstructured":"Bearman SI . The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005\u20133020.","journal-title":"Blood"},{"key":"BFtpj201665_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","volume":"379","author":"S Corbacioglu","year":"2012","unstructured":"Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet 2012; 379: 1301\u20131309.","journal-title":"Lancet"},{"key":"BFtpj201665_CR3","first-page":"1396","volume":"90","author":"S Cesaro","year":"2005","unstructured":"Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G et al. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica 2005; 90: 1396\u20131404.","journal-title":"Haematologica"},{"key":"BFtpj201665_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255\u2013267.","journal-title":"Ann Intern Med"},{"key":"BFtpj201665_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.bbmt.2008.12.489","volume":"15","author":"SO Ciurea","year":"2009","unstructured":"Ciurea SO, Andersson BS . Busulfan in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009; 15: 523\u2013536.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFtpj201665_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2217\/pgs.12.185","volume":"14","author":"M Hassan","year":"2013","unstructured":"Hassan M, Andersson BS . Role of pharmacogenetics in busulfan\/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation. Pharmacogenomics 2013; 14: 75\u201387.","journal-title":"Pharmacogenomics"},{"key":"BFtpj201665_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/bmt.2012.265","volume":"48","author":"M Ansari","year":"2013","unstructured":"Ansari M, Rezgui MA, Th\u00e9oret Y, Uppugunduri CR, Mezziani S, Vachon MF et al. Glutatione S-Transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients. Bone Marrow Transplant 2013; 48: 939\u2013946.","journal-title":"Bone Marrow Transplant"},{"key":"BFtpj201665_CR8","first-page":"6402","volume":"47","author":"WP Peters","year":"1987","unstructured":"Peters WP, Henner WD, Grochow LB, Olsen G, Edwards S, Stanbuck H et al. Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors. Cancer Res 1987; 47: 6402\u20136406.","journal-title":"Cancer Res"},{"key":"BFtpj201665_CR9","first-page":"135","volume":"10","author":"V Meresse","year":"1992","unstructured":"Meresse V, Hartmann O, Vassal G, Benhamou E, Valteau-Couanet D, Brugieres L et al. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant 1992; 10: 135\u2013141.","journal-title":"Bone Marrow Transplant"},{"key":"BFtpj201665_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/hep.510230326","volume":"23","author":"LD DeLeve","year":"1996","unstructured":"DeLeve LD, Wang X, Kuhlenkamp JF, Kaplowitz N . Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 1996; 23: 589\u2013599.","journal-title":"Hepatology"},{"key":"BFtpj201665_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1124\/dmd.106.012880","volume":"35","author":"J Bouligand","year":"2007","unstructured":"Bouligand J, Deroussent A, Simonnard N, Opolon P, Morizet J, Connault E et al. Induction of glutathione synthesis explains pharmacodynamics of high-dose busulfan in mice and highlights putative mechanisms of drug interaction. Drug Metab Dispos 2007; 35: 306\u2013314.","journal-title":"Drug Metab Dispos"},{"key":"BFtpj201665_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000028359","volume":"60","author":"LD DeLeve","year":"2000","unstructured":"DeLeve LD, Wang X . Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes. Pharmacology 2000; 60: 143\u2013154.","journal-title":"Pharmacology"},{"key":"BFtpj201665_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/bmt.2009.143","volume":"45","author":"M Ansari","year":"2010","unstructured":"Ansari M, Lauzon-Joset JF, Vachon MF, Duval M, Theoret Y, Champagne MA et al. Influence of GST gene polymorphisms on busulfan pharmacokinetics in children. Bone Marrow Transplant 2010; 45: 261\u2013267.","journal-title":"Bone Marrow Transplant"},{"key":"BFtpj201665_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED . Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116\u2013122.","journal-title":"Hepatology"},{"key":"BFtpj201665_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/00007890-198506000-00005","volume":"39","author":"GB McDonald","year":"1985","unstructured":"McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED . The clinical course of 53 patients with venocclusive disease of the liver after marrow transplantation. Transplantation 1985; 39: 603\u2013608.","journal-title":"Transplantation"},{"key":"BFtpj201665_CR16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC . Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009; 4: 1073\u20131081.","journal-title":"Nat Protoc"},{"key":"BFtpj201665_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1399-0004.2004.00250.x","volume":"65","author":"J Wang","year":"2004","unstructured":"Wang J, Huff AM, Spence JD, Hegele RA . Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration. Clin Genet 2004; 65: 483\u2013486.","journal-title":"Clin Genet"},{"key":"BFtpj201665_CR18","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1214\/14-AOAS735","volume":"8","author":"JY Tzeng","year":"2014","unstructured":"Tzeng JY, Lu W, Hsu FC . Gene-level pharmacogenetic analysis on survival outcomes using gene-trait similarity regression. Ann Appl Stat 2014; 8: 1232\u20131255.","journal-title":"Ann Appl Stat"},{"key":"BFtpj201665_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/bioinformatics\/btf869","volume":"19","author":"LW Hahn","year":"2003","unstructured":"Hahn LW, Ritchie MD, Moore JH . Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003; 19: 376\u2013382.","journal-title":"Bioinformatics"},{"issue":"Pt 4","key":"BFtpj201665_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley P, Lohkamp B, Scott WG, Cowtan K . Features and development of COOT. Acta Crystallogr D Biol Crystallogr 2010; 66 (Pt 4): 486\u2013501.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"BFtpj201665_CR21","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.bpj.2011.10.024","volume":"101","author":"D Xu","year":"2011","unstructured":"Xu D, Zhang Y . Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophys J 2011; 101: 2525\u20132534.","journal-title":"Biophys J"},{"key":"BFtpj201665_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/prot.10286","volume":"50","author":"SC Lovell","year":"2003","unstructured":"Lovell SC, Davis IW, Arendall WB 3rd, de Bakker PI, Word JM, Prisant MG et al. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 2003; 50: 437\u2013450.","journal-title":"Proteins"},{"key":"BFtpj201665_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O'Boyle","year":"2011","unstructured":"O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR . Open Babel: an open chemical toolbox. J Cheminform 2011; 3: 33.","journal-title":"J Cheminform"},{"key":"BFtpj201665_CR24","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","volume":"19","author":"GMGD Morris","year":"1999","unstructured":"Morris GM GD, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ . Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J Comput Chem 1999; 19: 1639\u20131662.","journal-title":"J Comput Chem"},{"key":"BFtpj201665_CR25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ . AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010; 31: 455\u2013461.","journal-title":"J Comput Chem"},{"key":"BFtpj201665_CR26","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB . LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 2011; 51: 2778\u20132786.","journal-title":"J Chem Inf Model"},{"key":"BFtpj201665_CR27","doi-asserted-by":"publisher","first-page":"e67008","DOI":"10.1371\/journal.pone.0067008","volume":"8","author":"JS Chauhan","year":"2013","unstructured":"Chauhan JS, Rao A, Raghava GP . In silico platform for prediction of N-, O- and C-glycosites in eukaryotic protein sequences. PLoS One 2013; 8: e67008.","journal-title":"PLoS One"},{"key":"BFtpj201665_CR28","doi-asserted-by":"publisher","first-page":"32403","DOI":"10.1074\/jbc.M605149200","volume":"281","author":"TA Gerken","year":"2006","unstructured":"Gerken TA, Raman J, Fritz TA, Jamison O . Identification of common and unique peptide substrate preferences for the UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases T1 and T2 derived from oriented random peptide substrates. J Biol Chem 2006; 281: 32403\u201332416.","journal-title":"J Biol Chem"},{"key":"BFtpj201665_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2105-5-79","volume":"5","author":"F Diella","year":"2004","unstructured":"Diella F, Cameron S, Gemund C, Linding R, Via A, Kuster B et al. Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins. BMC Bioinformatics 2004; 5: 79.","journal-title":"BMC Bioinformatics"},{"key":"BFtpj201665_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00694339","volume":"25","author":"LB Grochow","year":"1989","unstructured":"Grochow LB, Jones RJ, Brundrett RB, Braine HG, Chen TL, Saral R et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1989; 25: 55\u201361.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFtpj201665_CR31","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/sj.bmt.1702377","volume":"25","author":"M Hassan","year":"2000","unstructured":"Hassan M, Ljungman P, Ringden O, Hassan Z, Oberg G, Nilsson C et al. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity. Bone Marrow Transplant 2000; 25: 915\u2013924.","journal-title":"Bone Marrow Transplant"},{"key":"BFtpj201665_CR32","unstructured":"Busulfex. [prescribing information]. Accessed 17 Februay 2012 (cited; available from: http:\/\/www.ema.europa.eu ."},{"key":"BFtpj201665_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-2002-23204","volume":"22","author":"LD DeLeve","year":"2002","unstructured":"DeLeve LD, Shulman HM, McDonald GB . Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22: 27\u201342.","journal-title":"Semin Liver Dis"},{"key":"BFtpj201665_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1753-4887.1984.tb02277.x","volume":"42","author":"A Meister","year":"1984","unstructured":"Meister A . New aspects of glutathione biochemistry and transport\u2014selective alteration of glutathione metabolism. Nutr Rev 1984; 42: 397\u2013410.","journal-title":"Nutr Rev"},{"key":"BFtpj201665_CR35","doi-asserted-by":"publisher","first-page":"21202","DOI":"10.3390\/ijms151121202","volume":"15","author":"A Pastore","year":"2014","unstructured":"Pastore A, Alisi A, di Giovamberardino G, Crudele A, Ceccarelli S, Panera N et al. Plasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage. Int J Mol Sci 2014; 15: 21202\u201321214.","journal-title":"Int J Mol Sci"},{"key":"BFtpj201665_CR36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ymgme.2009.04.001","volume":"97","author":"JP Kraus","year":"2009","unstructured":"Kraus JP, Hasek J, Kozich V, Collard R, Venezia S, Janosikova B et al. Cystathionine gamma-lyase: clinical, metabolic, genetic, and structural studies. Mol Genet Metab 2009; 97: 250\u2013259.","journal-title":"Mol Genet Metab"},{"key":"BFtpj201665_CR37","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1093\/jn\/133.8.2643","volume":"133","author":"A Must","year":"2003","unstructured":"Must A, Jacques PF, Rogers G, Rosenberg IH, Selhub J . Serum total homocysteine concentrations in children and adolescents: results from the third National Health and Nutrition Examination Survey (NHANES III). J Nutr 2003; 133: 2643\u20132649.","journal-title":"J Nutr"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/tpj201665.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/tpj201665","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/tpj.2016.65","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/tpj201665.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T04:58:56Z","timestamp":1718859536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj201665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,25]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFtpj201665"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2016.65","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,25]]},"assertion":[{"value":"12 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}